Cardiovascular diseases (CVD) constitute the main cause of death worldwide. Because of this, preventing their appearance by controlling the main risk factors is key, most CVDs may be prevented by tackling these risk factors, like smoking, unhealthy diets and obesity, physical inactivity or excessive alcohol intake, and this may be done by introducing strategies that are inclusive of the entire population.
In addition to modifying these habits, certain people might require pharmacological treatment to help maintain cardiovascular risk factors under control. Following the appearance of a first event, the correct handling of these risk factors becomes even more important due to a second event being more possible.
It is estimated that 30% of post-stroke patients suffer a second stroke within 5 years. This makes having a preventive plan to reduce cardiovascular risk among this collective in place crucial.
2. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119.
3. Protocolo Hipertensión Pulmonar SEMI. ©2011 Sociedad Española de Medicina Interna y Elsevier España, S.L. ISBN: 978-84-7592-725-1
4. Quezada Loaiza CA, Velázquez Martín MT, Jiménez López-Guarch C, Ruiz Cano MJ, Navas Tejedor P, Esmeralda Carreira P, Flox Camacho A, de Pablo Gafas A, Delgado Jiménez JF, Gómez Sánchez MA, Escribano Subías P. La evolución de la hipertensión arterial pulmonar a lo largo de 30 años: experiencia de un centro de referencia. Rev Esp Cardiol 2017;70:915-23
5. Organización de pacientes Hipertensión Pulmonar España: https://www.hipertension-pulmonar.com/hipertension-pulmonar/